	US 12,274,718 B2
	Composition and method for preventing, alleviating, or treating liver injury
Gwang Pyo Ko, Seoul (KR); Won Kim, Seoul (KR); Hyun Ju You, Incheon (KR); Giljae Lee, Seoul (KR); and Bo-Ram Cho, Seoul (KR)
Assigned to KOBIOLABS, INC., Seoul (KR)
Appl. No. 17/626,628
Filed by KoBioLabs, Inc., Seoul (KR)
PCT Filed Jul. 30, 2020, PCT No. PCT/KR2020/010097 § 371(c)(1), (2) Date Jan. 12, 2022, PCT Pub. No. WO2021/020923, PCT Pub. Date Feb. 4, 2021.
Claims priority of application No. 10-2019-0092689 (KR), filed on Jul. 30, 2019; application No. 10-2020-0087105 (KR), filed on Jul. 14, 2020; application No. 10-2020-0094922 (KR), filed on Jul. 30, 2020; and application No. 10-2020-0095361 (KR), filed on Jul. 30, 2020.
Prior Publication US 2022/0257669 A1, Aug. 18, 2022
Int. Cl. A61K 39/02 (2006.01); A23L 33/135 (2016.01); A61K 35/74 (2015.01); A61P 1/16 (2006.01); C12N 1/20 (2006.01); G01N 33/569 (2006.01)

CPC A61K 35/74 (2013.01) [A23L 33/135 (2016.08); A61P 1/16 (2018.01); C12N 1/20 (2013.01); G01N 33/56916 (2013.01); G01N 2333/26 (2013.01); G01N 2333/36 (2013.01)]

14 Claims

1. A method for alleviating or treating nonalcoholic fatty liver disease, comprising administering a pharmaceutical or food composition comprising a Ruminococcus faecis strain with accession number KCTC No. 5757 to a subject.